Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Relation of the Expression of Cyclooxygenase-2 in Colorectal Adenomas and Adenocarcinomas to Angiogenesis and Prognosis

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2010³â 26±Ç 5È£ p.339 ~ 346
ÇÑÀ±´ë, È«¿µ±â, °­Áß±¸, ÃÖÀ±Á¤, ¹ÚÂùÈç,
¼Ò¼Ó »ó¼¼Á¤º¸
ÇÑÀ±´ë ( Han Yoon-Dae ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

È«¿µ±â ( Hong Young-Ki ) 
±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø ¿Ü°úÇб³½Ç
°­Áß±¸ ( Kang Jung-Gu ) 
±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø ¿Ü°úÇб³½Ç
ÃÖÀ±Á¤ ( Choi Yoon-Jung ) 
±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø º´¸®°ú
¹ÚÂùÈç ( Park Chan-Heun ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ °­µ¿¼º½Éº´¿ø ¿Ü°úÇб³½Ç

Abstract


Purpose Recent studies have shown that cyclooxygenase (COX)-2 may be involved in tumor growth, invasion and apoptosis in various carcinomas. Vascular endothelial growth factor (VEGF) has a potent angiogenic activity, and COX-2 promotes angiogenesis by modulating angiogenic factors, including VEGF. Endothelial growth factor receptor (EGFR) is considered as a factor of cell growth, maturation and cell death. The current study was designed to investigate the possible roles of COX-2 in colorectal tumor progression and angiogenesis.

Methods Fifty colorectal adenomas and forty adenocarcinomas were investigated by using immunohistochemical staining for COX-2, VEGF and EGFR. The correlations of COX-2, VEGF and EGFR with the grade of dysplasia, the size of the adenoma, and various clinicopathologic factors were studied.

Results The expressions of COX-2, VEGF and EGFR were each significantly correlated with carcinomatous transformation, and the expressions of COX-2 and VEGF were significantly correlated. COX-2 and EGFR showed correlations with adenomas rather than adenocarcinomas. However, no correlations of COX-2, VEGF and EGFR expression to other clinicopathologic factors, except tumor size in EGFR expression, were detected.

Conclusion These results suggest that COX-2 may play an important role in carcinogenesis through interaction with VEGF and EGFR in human colorectal cancer.

Å°¿öµå

Cyclooxygenase 2; Vascular endothelial growth factor; Endothelial growth factor receptor; Colorectal carcinoma; Adenocarcinoma

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS